Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formation
Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans
Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans
View: Text | PDF
Research Article Pulmonology Virology

Alveolar barrier disruption in varicella pneumonia is associated with neutrophil extracellular trap formation

  • Text
  • PDF
Abstract

Primary varicella-zoster virus (VZV) infection in adults is often complicated by severe pneumonia, which is difficult to treat and is associated with high morbidity and mortality. Here, the simian varicella virus (SVV) nonhuman primate (NHP) model was used to investigate the pathogenesis of varicella pneumonia. SVV infection resulted in transient fever, viremia, and robust virus replication in alveolar pneumocytes and bronchus-associated lymphoid tissue. Clearance of infectious virus from lungs coincided with robust innate immune responses, leading to recruitment of inflammatory cells, mainly neutrophils and lymphocytes, and finally severe acute lung injury. SVV infection caused neutrophil activation and formation of neutrophil extracellular traps (NETs) in vitro and in vivo. Notably, NETs were also detected in lung and blood specimens of varicella pneumonia patients. Lung pathology in the SVV NHP model was associated with dysregulated expression of alveolar epithelial cell tight junction proteins (claudin-2, claudin-10, and claudin-18) and alveolar endothelial adherens junction protein VE-cadherin. Importantly, factors released by activated neutrophils, including NETs, were sufficient to reduce claudin-18 and VE-cadherin expression in NHP lung slice cultures. Collectively, the data indicate that alveolar barrier disruption in varicella pneumonia is associated with NET formation.

Authors

Werner J.D. Ouwendijk, Henk-Jan van den Ham, Mark W. Delany, Jeroen J.A. van Kampen, Gijsbert P. van Nierop, Tamana Mehraban, Fatiha Zaaraoui-Boutahar, Wilfred F.J. van IJcken, Judith M.A. van den Brand, Rory D. de Vries, Arno C. Andeweg, Georges M.G.M. Verjans

×

Figure 1

SVV infection of cynomolgus macaques causes transient fever and fulminant pneumonia.

Options: View larger image (or click on image) Download as PowerPoint
SVV infection of cynomolgus macaques causes transient fever and fulminan...
(A) Experimental design. Time relative to mock or SVV infection (day 0) is indicated. Sampling time points and type are indicated by open (BAL) and closed (blood) inverted triangles. (B) Fluctuations in body temperature after mock (control) and SVV infection. Horizontal dashed lines, normal range in body temperature. Black solid line, mean. Gray filled area, 95% CI. Control, n = 5; SVV infection, n = 15 for 1–3 dpi, n = 10 for 4–6 dpi, and n = 5 for 7–9 dpi. (C, D, and F) SVV DNA qPCR on PBMC (C), BAL cells (D) and lung tissue (F). Data are expressed as SVV genomic DNA (gDNA) copies per 1 × 105 cells. (E) Infectious SVV titers in BAL cells. (C–F) Symbols indicate values of individual animals (group 1, filled square; group 2, open square; group 3, filled triangle); black horizontal line indicates median. (G) Photographs of lungs from control and SVV-infected animals. Arrows indicate lesions.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts